Spots Global Cancer Trial Database for fk228 (romidepsin)
Every month we try and update this database with for fk228 (romidepsin) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Research Study for Patients With Metastatic Renal Cell Carcinoma | NCT00106613 | Carcinoma, Rena... Neoplasm Metast... | FK228 (romideps... | 18 Years - | Celgene | |
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 | NCT00106301 | Carcinoma, Rena... Prostatic Neopl... | FK228 (romideps... | 18 Years - | Celgene | |
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 | NCT00106301 | Carcinoma, Rena... Prostatic Neopl... | FK228 (romideps... | 18 Years - | Celgene | |
A Research Study for Patients With Metastatic Renal Cell Carcinoma | NCT00106613 | Carcinoma, Rena... Neoplasm Metast... | FK228 (romideps... | 18 Years - | Celgene | |
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 | NCT00106301 | Carcinoma, Rena... Prostatic Neopl... | FK228 (romideps... | 18 Years - | Celgene |